31 Aug 2022 reMYND identifies novel target and small molecules with potential to halt and reverse disease progression in Huntington’s disease through oral administration Member news
25 Aug 2022 Biocartis obtains ISO 27001 certification for information security management Member news
23 Aug 2022 mRNA leading expert Kenneth Chien and Novalis LifeSciences’ Marijn Dekkers investing in EUR 39M Series B2 financing of mRNA technology platform company eTheRNA Member news
11 Aug 2022 argenx announces European Commission approval of VYVGART™ (efgartigimod alfa-fcab) for the treatment of generalized myasthenia gravis Member news
10 Aug 2022 Bone Therapeutics to broaden and derisk therapeutic portfolio by acquiring majority participation in Medsenic Member news
08 Aug 2022 Mayne Pharma and Mithra announce FDA approval of HALOETTE®, a generic version of NUVARING® Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us